What is workflow intelligence in digital health tech?

The real gap in digital health tools

Healthcare AI spending in the US nearly tripled last year, yet the AMA survey of physicians found that even with most physicians already using AI tools, nearly half still wanted more oversight before trusting what those tools recommended.

Digital health developers can keep layering in new content, data, and AI features, but more features may not contribute to gaining and maintaining user trust. What clinicians and patients need is trusted intelligence integrated into the workflow: evidence-based clinical guidance delivered when users need to understand, decide, or act, along with medication intelligence structured for consistent and reviewable application.

That's because quality healthcare experiences don't happen in one siloed instance of care. Digital healthcare technology companies need to connect clinical decision support, medication workflows, and patient education throughout the care journey. Buyers want intelligence that works within the systems and workflows they already use, not another solution to manage. Connecting those pieces creates a seamless, consistent experience that users can trust.

The hidden cost of building AI features alone

The global healthcare AI market isn't slowing down: research projects it will grow from $50.7 billion to $505.6 billion by 2033. Physician use of AI is climbing right along with it, up from about 38% a few years ago to roughly 81% today.

That pace pressures product and engineering teams to launch new capabilities quickly. Building AI-enabled content in-house means taking on the validation, maintenance, and updates that clinical intelligence, medication logic, drug data, and patient education all require. That complexity tends to slow teams down instead of speeding them up.

Teams that build on trusted, expertly maintained healthcare intelligence can reduce that burden. It gives them a foundation already structured for digital workflows, helping free them to focus on the innovation that actually sets their product apart.

A shared foundation for healthcare workflow intelligence

Digital health companies need access to intelligence that ties clinical guidance, medication decision support, and patient education together, so users get consistent support instead of disconnected experiences.

To support development teams, Wolters Kluwer’s digital health strategy is a connected intelligence layer that promotes trust and consistency across the digital health experience:

• UpToDate® Connect: Evidence-based clinical guidance and AI-powered insights integrated into digital health platforms at the point of care, bringing decision support closer to the moments where clinicians document, triage, communicate, coordinate, and decide.
• UpToDate® Consumer Education: Patient-facing health education integrated into care manager workflows helps users support patient understanding and follow-through beyond the clinical encounter.
• Medi-Span® drug data: Trusted medication decision support that provides structured, evidence-based drug and therapeutic data, pricing intelligence, and clinical screening capabilities.
• Medi-Span® Expert AI: AI-ready medication intelligence that supports the repeatable, traceable, and reviewable application of medication information.

What sets a trusted digital health product apart

A workflow-integrated clinical intelligence foundation matters more as AI expands into scheduling, care navigation, and documentation, while governance concerns grow. Shadow AI is also raising oversight questions. Trusted clinical guidance and traceable medication intelligence can support governance without requiring teams to develop every intelligence layer internally.

It also helps products stand out. As capital concentrates around fewer, larger digital health companies and patient-facing AI moves beyond chat, trusted guidance, maintained medication intelligence, and timely patient education become harder to copy.

AI alone does not create trust. Evidence-based guidance, trusted therapeutic and medication intelligence, and clinically grounded patient education do, and that foundation can become a meaningful competitive advantage.